Page 1 of 85
PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE
PRESCRIBERS PREP 2026 QUESTIONS WITH VERIFIED ANSWERS
DETAILED RATIONALES GRADED A+
Part I: The Role of the APRN as Prescriber (Questions 1–30)
1. Nurse practitioner prescriptive authority in the United States is regulated
primarily by which entity?
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
Rationale: Prescriptive authority is granted and regulated at the state level by
each state’s Board of Nursing, which determines the scope of practice for APRNs.
2. Which of the following is a benefit to patients of having an APRN prescriber?
A. APRNs know more about pharmacology than other prescribers
B. APRNs care for patients holistically and include them in decision-making
regarding their care
C. APRNs are less likely to prescribe narcotics
D. APRNs can prescribe independently in all states without restrictions
Rationale: APRNs bring a holistic approach to prescribing, including the patient in
shared decision-making, which enhances patient-centered care.
3. Clinical judgment in prescribing includes which of the following considerations?
A. Always prescribing the newest medication available
B. Factoring in the cost of the medication to the patient
1|Page
,Page 2 of 85
C. Handing out drug samples to all patients
D. Prescribing only generic medications to cut costs
Rationale: Clinical judgment requires balancing efficacy, safety, and cost, including
the patient’s ability to afford the prescribed therapy.
4. Criteria for choosing an effective drug for a disorder include which of the
following?
A. Asking the patient what drug they think would work best
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples
D. Following DEA guidelines for prescribing
Rationale: Nationally recognized clinical guidelines provide evidence-based
recommendations for drug selection, ensuring effective and safe therapy.
5. An APRN is reviewing the principle of drug selection for a patient with
hypertension. According to the textbook, which factor should be the primary
consideration when selecting a pharmacotherapeutic agent?
A. The patient’s individual characteristics, comorbidities, and clinical evidence
B. Cost of the medication alone
C. The newest available medication
D. The medication most frequently used by colleagues
Rationale: Evidence-based prescribing integrates clinical evidence, patient-specific
factors, clinician expertise, and patient preferences, rather than relying on novelty,
cost alone, or anecdotal practice.
6. A 74-year-old woman with chronic kidney disease, heart failure, osteoarthritis,
and insomnia takes nine prescription medications. Which prescribing strategy
should the APRN prioritize?
A. Add medications to treat every reported symptom
B. Perform a comprehensive medication reconciliation to identify therapeutic
duplication, interactions, and deprescribing opportunities
2|Page
,Page 3 of 85
C. Continue all current medications because they were prescribed by specialists
D. Avoid modifying medications until every specialist agrees
Rationale: Medication reconciliation is essential in older adults with
polypharmacy to reduce medication-related harm, identify duplicate therapies,
and consider deprescribing.
7. An AGPCNP evaluates a patient with newly diagnosed hypertension who wishes
to minimize medication burden while maintaining an active lifestyle. Which
response best reflects shared decision-making?
A. "I'll prescribe what current guidelines recommend without discussing
alternatives."
B. "We'll review available treatment options, expected benefits, potential
adverse effects, and your preferences before deciding together."
C. "Because hypertension requires medication, lifestyle preferences should not
influence therapy."
D. "I'll prescribe the medication with the fewest adverse effects regardless of your
goals."
Rationale: Shared decision-making ensures that treatment aligns with the
patient’s values and preferences, which is a cornerstone of advanced practice
prescribing.
8. In how many states do APRNs have fully autonomous practice and prescriptive
authority?
A. 12 states
B. 27 states, the District of Columbia, and Guam
C. 50 states
D. 5 states
Rationale: As of current regulatory data, 27 states, the District of Columbia, and
Guam grant APRNs fully autonomous practice and prescriptive authority.
9. In states requiring supervised prescriptive authority, what must an APRN
typically complete before achieving full autonomous practice?
3|Page
, Page 4 of 85
A. A doctoral degree
B. A period of supervision or collaboration with a physician
C. Additional board certification
D. A residency program
Rationale: Supervised prescriptive authority requires a defined period of
supervision or collaboration before the APRN can practice autonomously.
10. What is required for an APRN to prescribe controlled substances?
A. Only a state nursing license
B. A DEA registration number in addition to state authority
C. A hospital privileges letter
D. A pharmacy board certification
Rationale: Federal law requires a DEA registration for any prescriber of controlled
substances, in addition to state-level prescriptive authority.
11. Which schedule of controlled substances are APRNs prohibited from
prescribing in some states?
A. Schedule IV
B. Schedule III
C. Schedule II
D. Schedule V
Rationale: A small number of states restrict APRN prescribing of Schedule II
medications, though most allow it with appropriate authority.
12. An APRN is checking the Prescription Drug Monitoring Program (PDMP) before
prescribing a controlled substance. What is the primary purpose of this action?
A. To verify the patient’s insurance coverage
B. To identify potential misuse, duplicate prescriptions, and controlled substance
history
C. To determine the patient’s preferred pharmacy
D. To calculate the cost of the medication
4|Page
PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE
PRESCRIBERS PREP 2026 QUESTIONS WITH VERIFIED ANSWERS
DETAILED RATIONALES GRADED A+
Part I: The Role of the APRN as Prescriber (Questions 1–30)
1. Nurse practitioner prescriptive authority in the United States is regulated
primarily by which entity?
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
Rationale: Prescriptive authority is granted and regulated at the state level by
each state’s Board of Nursing, which determines the scope of practice for APRNs.
2. Which of the following is a benefit to patients of having an APRN prescriber?
A. APRNs know more about pharmacology than other prescribers
B. APRNs care for patients holistically and include them in decision-making
regarding their care
C. APRNs are less likely to prescribe narcotics
D. APRNs can prescribe independently in all states without restrictions
Rationale: APRNs bring a holistic approach to prescribing, including the patient in
shared decision-making, which enhances patient-centered care.
3. Clinical judgment in prescribing includes which of the following considerations?
A. Always prescribing the newest medication available
B. Factoring in the cost of the medication to the patient
1|Page
,Page 2 of 85
C. Handing out drug samples to all patients
D. Prescribing only generic medications to cut costs
Rationale: Clinical judgment requires balancing efficacy, safety, and cost, including
the patient’s ability to afford the prescribed therapy.
4. Criteria for choosing an effective drug for a disorder include which of the
following?
A. Asking the patient what drug they think would work best
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples
D. Following DEA guidelines for prescribing
Rationale: Nationally recognized clinical guidelines provide evidence-based
recommendations for drug selection, ensuring effective and safe therapy.
5. An APRN is reviewing the principle of drug selection for a patient with
hypertension. According to the textbook, which factor should be the primary
consideration when selecting a pharmacotherapeutic agent?
A. The patient’s individual characteristics, comorbidities, and clinical evidence
B. Cost of the medication alone
C. The newest available medication
D. The medication most frequently used by colleagues
Rationale: Evidence-based prescribing integrates clinical evidence, patient-specific
factors, clinician expertise, and patient preferences, rather than relying on novelty,
cost alone, or anecdotal practice.
6. A 74-year-old woman with chronic kidney disease, heart failure, osteoarthritis,
and insomnia takes nine prescription medications. Which prescribing strategy
should the APRN prioritize?
A. Add medications to treat every reported symptom
B. Perform a comprehensive medication reconciliation to identify therapeutic
duplication, interactions, and deprescribing opportunities
2|Page
,Page 3 of 85
C. Continue all current medications because they were prescribed by specialists
D. Avoid modifying medications until every specialist agrees
Rationale: Medication reconciliation is essential in older adults with
polypharmacy to reduce medication-related harm, identify duplicate therapies,
and consider deprescribing.
7. An AGPCNP evaluates a patient with newly diagnosed hypertension who wishes
to minimize medication burden while maintaining an active lifestyle. Which
response best reflects shared decision-making?
A. "I'll prescribe what current guidelines recommend without discussing
alternatives."
B. "We'll review available treatment options, expected benefits, potential
adverse effects, and your preferences before deciding together."
C. "Because hypertension requires medication, lifestyle preferences should not
influence therapy."
D. "I'll prescribe the medication with the fewest adverse effects regardless of your
goals."
Rationale: Shared decision-making ensures that treatment aligns with the
patient’s values and preferences, which is a cornerstone of advanced practice
prescribing.
8. In how many states do APRNs have fully autonomous practice and prescriptive
authority?
A. 12 states
B. 27 states, the District of Columbia, and Guam
C. 50 states
D. 5 states
Rationale: As of current regulatory data, 27 states, the District of Columbia, and
Guam grant APRNs fully autonomous practice and prescriptive authority.
9. In states requiring supervised prescriptive authority, what must an APRN
typically complete before achieving full autonomous practice?
3|Page
, Page 4 of 85
A. A doctoral degree
B. A period of supervision or collaboration with a physician
C. Additional board certification
D. A residency program
Rationale: Supervised prescriptive authority requires a defined period of
supervision or collaboration before the APRN can practice autonomously.
10. What is required for an APRN to prescribe controlled substances?
A. Only a state nursing license
B. A DEA registration number in addition to state authority
C. A hospital privileges letter
D. A pharmacy board certification
Rationale: Federal law requires a DEA registration for any prescriber of controlled
substances, in addition to state-level prescriptive authority.
11. Which schedule of controlled substances are APRNs prohibited from
prescribing in some states?
A. Schedule IV
B. Schedule III
C. Schedule II
D. Schedule V
Rationale: A small number of states restrict APRN prescribing of Schedule II
medications, though most allow it with appropriate authority.
12. An APRN is checking the Prescription Drug Monitoring Program (PDMP) before
prescribing a controlled substance. What is the primary purpose of this action?
A. To verify the patient’s insurance coverage
B. To identify potential misuse, duplicate prescriptions, and controlled substance
history
C. To determine the patient’s preferred pharmacy
D. To calculate the cost of the medication
4|Page
